Back to Agenda
Strengthening Public Policy for Sustainable Clinical Research Enterprise in Africa, Asia, and South America: Progress and Prospects
Session Chair(s)
Ekopimo O. Ibia, MD, MPH, FRCP
Director, Medical Safety Review
Merck & Co., Inc; FDA Alumni Association International Network, United States
This session examines evolving significant policies and initiatives about clinical research in Africa, Asia, and South America. The session will also provide information on potential linkages to regulatory pathways and initiatives in the US/EU that could assist product development and registration.
Learning Objective : Discuss progress made in promoting the clinical research infrastructure in Africa, Asia, and South America; Recognize evolving public policies aimed at further strengthening the clinical research environment in the regions; Restate shared experiences and best practices to identify potential opportunities to locate clinical trials in these regions.
Speaker(s)
Clinical Research in South America
Maria João Queiroz, MD
CTI-Clinical Trial and Consulting, Portugal
Vice-President, Real World Evidence
APEC Regulatory Harmonization Steering Committee and Its Impact on Clinical Trials
Florence Houn, MD, MPH, FACP
Florence Houn MD MPH LLC, United States
Consultant
Clinical Trial Environment in Africa
Thomas Nyirenda, MD, MS
European & Developing Countries Clinical Trials Partnership (EDCTP), South Africa
South-South Networking and Capacity Development Manager
Have an account?